The purpose of this national diagnosis and treatment protocol (PNDS) is to outline to health providers the optimum management and integrated care pathway for patients with long-term conditions (ALD), particularly with status ALD 11: xeroderma pigmentosum (XP).
See also
HAS opinions and decisions
17/06/2009
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
Dhwr73uz5ePgwp9E
